Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder

Arpamas Seetasith,1 Mallik Greene,2 Ann Hartry,3 Chakkarin Burudpakdee1 1Medical and Scientific Services, Real-World Evidence Solutions, IQVIA, Falls Church, VA 22042, USA; 2Health Economics and Outcomes Research, Otsuka Pharmaceutical Development And Commercialization, Inc., Princeton, NJ 08540, US...

Full description

Bibliographic Details
Main Authors: Seetasith A, Greene M, Hartry A, Burudpakdee C
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
atypical antipsychotic agents
comparative effectiveness research
health care utilization
healthcare costs
propensity score matching
Online Access:https://www.dovepress.com/real-world-economic-outcomes-of-brexpiprazole-and-extended-release-que-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/real-world-economic-outcomes-of-brexpiprazole-and-extended-release-que-peer-reviewed-article-CEOR

Similar Items